Schleussner, Nikolai 
ORCID: 0009-0001-3549-5600, Knipper, Karl ORCID: 0009-0008-7133-3538, Leugner, Ella, Goddemeier, Christian, Yasar, Uraz, Wirsik, Naita M. ORCID: 0000-0003-1619-6354, Jung, Jin-On ORCID: 0000-0001-6121-0114, Fuchs, Hans F. ORCID: 0000-0003-4764-8050, Schiffmann, Lars M. ORCID: 0000-0002-2320-5004, Quaas, Alexander ORCID: 0000-0002-3537-6011, Bruns, Christiane J. ORCID: 0000-0001-6590-8181 and Schmidt, Thomas ORCID: 0000-0002-7166-3675
(2025).
The AP-1 factor JUNB correlates with poor survival of patients with esophageal adenocarcinoma.
Scientific Reports, 15 (1).
pp. 1-10.
Springer Nature.
ISSN 2045-2322
![[thumbnail of s41598-025-07393-9.pdf]](http://kups.ub.uni-koeln.de/style/images/fileicons/application_pdf.png "s41598-025-07393-9.pdf") |
PDF
s41598-025-07393-9.pdf Bereitstellung unter der CC-Lizenz: Creative Commons Attribution. Download (2MB) |
Abstract
[Artikel-Nr.: 26790] Malignant cells have in contrast to non-transformed cells de-regulated transcriptional networks. The activator protein-1 (AP-1) transcription factor complex is expressed in many cancer entities including adenocarcinomas and has been correlated to de-regulated transcription and tumor-promoting mechanisms. Despite complex treatment approaches, esophageal cancer is still associated with poor overall survival. There is an urgent need for better patient stratification to increase the outcome of the multimodal treatment. This study investigated the expression of two AP-1 factors, cJUN and JUNB, and their role in 735 patients with esophageal cancer undergoing surgery. We performed immunohistochemical stainings for cJUN and JUNB and correlated the expression to the clinical outcome. Patients with a high JUNB expression level correlate to a reduced overall survival (OS) compared to patients with a low expression. Furthermore, in the multivariate analysis high JUNB expression was shown to be an independent risk factor for reduced patient survival. In addition, subgroup analysis demonstrated a significantly reduced OS for high JUNB expression in the subgroup of patients with neoadjuvant treatment. Strikingly, tumors co-expressing cJUN and JUNB were associated with poorer overall survival compared to those expressing only one or neither of the transcriptions factors. Our study suggests JUN expression as a novel biomarker to stratify patients, especially in the subgroup of neoadjuvant treated patients. Our findings have translational implications as targeting JUN might complement current available multimodal treatment approaches.
| Item Type: | Article |
| Creators: | Creators Email ORCID ORCID Put Code Leugner, Ella UNSPECIFIED UNSPECIFIED UNSPECIFIED Goddemeier, Christian UNSPECIFIED UNSPECIFIED UNSPECIFIED Yasar, Uraz UNSPECIFIED UNSPECIFIED UNSPECIFIED |
| URN: | urn:nbn:de:hbz:38-809535 |
| Identification Number: | 10.1038/s41598-025-07393-9 |
| Journal or Publication Title: | Scientific Reports |
| Volume: | 15 |
| Number: | 1 |
| Page Range: | pp. 1-10 |
| Number of Pages: | 10 |
| Date: | 23 July 2025 |
| Publisher: | Springer Nature |
| ISSN: | 2045-2322 |
| Language: | English |
| Faculty: | Faculty of Medicine |
| Divisions: | Faculty of Medicine > Chirurgie > Klinik und Poliklinik für Allgemein-, Viszeral-, Thorax- und Transplantationschirurgie Faculty of Medicine > Pathologie und Neuropathologie > Institut für Pathologie |
| Subjects: | Medical sciences Medicine |
| Uncontrolled Keywords: | Keywords Language Esophageal adenocarcinoma ; AP-1 ; CJUN ; JUNB ; Targeted therapy ; Individualized medicine English |
| ['eprint_fieldname_oa_funders' not defined]: | Publikationsfonds UzK |
| Refereed: | Yes |
| URI: | http://kups.ub.uni-koeln.de/id/eprint/80953 |
https://orcid.org/0009-0001-3549-5600Downloads
Downloads per month over past year
Altmetric
Export
Actions (login required)
 |
View Item |